Hain Lifescience Limited Filleted accounts for Companies House (small and micro)

HAIN LIFESCIENCE LTD. - Company Information

false false false false false false false false false true false false false false false false false No description of principal activity 2018-01-01 Sage Accounts Production Advanced 2018 - FRS xbrli:pure xbrli:shares iso4217:GBP 07750969 2018-01-01 2018-12-31 07750969 2018-12-31 07750969 2017-12-31 07750969 bus:LeadAgentIfApplicable 2018-01-01 2018-12-31 07750969 bus:Director3 2018-01-01 2018-12-31 07750969 core:WithinOneYear 2018-12-31 07750969 core:WithinOneYear 2017-12-31 07750969 core:ShareCapital 2018-12-31 07750969 core:ShareCapital 2017-12-31 07750969 core:RetainedEarningsAccumulatedLosses 2018-12-31 07750969 core:RetainedEarningsAccumulatedLosses 2017-12-31 07750969 bus:SmallEntities 2018-01-01 2018-12-31 07750969 bus:AuditExemptWithAccountantsReport 2018-01-01 2018-12-31 07750969 bus:FullAccounts 2018-01-01 2018-12-31 07750969 bus:SmallCompaniesRegimeForAccounts 2018-01-01 2018-12-31 07750969 bus:PrivateLimitedCompanyLtd 2018-01-01 2018-12-31

COMPANY REGISTRATION NUMBER: 07750969

Hain Lifescience Limited

Filleted Unaudited Financial Statements

31 December 2018

Hain Lifescience Limited

Financial Statements

Year ended 31 December 2018

Contents	Page

Chartered certified accountants report to the board of directors on the preparation of the unaudited statutory financial statements	1

Statement of financial position	2

Accounting policies	3

Notes to the financial statements	4

Hain Lifescience Limited

Chartered Certified Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Hain Lifescience Limited

Year ended 31 December 2018

As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 31 December 2018, which comprise the statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.

BODDINGTON & COMPANY LIMITED Chartered Certified Accountants

3 Churchmeadows Bulford Road Shipton Bellinger Tidworth Hampshire SP9 7RL

23 September 2019

Hain Lifescience Limited

Statement of Financial Position

31 December 2018

	2018		2017
Note	£	£	£

Current assets

Debtors	3	90,718		90,718

Creditors: amounts falling due within one year	4	29,683		29,683
		--------		--------
Net current assets			61,035	61,035
			--------	--------
Total assets less current liabilities			61,035	61,035
			--------	--------

Capital and reserves

Called up share capital	1	1
Profit and loss account	61,034	61,034
	--------	--------
Shareholders funds	61,035	61,035
	--------	--------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the year ending 31 December 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 20 September 2019 , and are signed on behalf of the board by:

Mr D. A. Hain

Director

Company registration number: 07750969

Hain Lifescience Limited

Accounting Policies

Year ended 31 December 2018

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Hain Lifescience Limited

Notes to the Financial Statements

Year ended 31 December 2018

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 4 Byfleet Technical Centre, West Byfleet, Surrey, KT14 7JX, England.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Debtors

	2018	2017
	£	£
Amounts owed by group undertakings and undertakings in which the company has a participating interest	90,718	90,718
	--------	--------

4. Creditors: amounts falling due within one year

	2018	2017
	£	£
Amounts owed to group undertakings and undertakings in which the company has a participating interest	29,683	29,683
	--------	--------

5. Employee numbers

The average number of persons employed by the company during the year was 0 (2017: 0).